Skip to content

Investigation of expression of miRNA in serum exosomal and potential mechanisms in lung adenocarcinoma

Investigation of expression of miRNA in serum exosomal and potential mechanisms in lung adenocarcinoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034552
Enrollment
Unknown
Registered
2020-07-09
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Gold Standard:Pathology
of&#32
in&#32
serum&#32

Sponsors

Qingdao Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Chest CT examination was performed for patients with pulmonary nodules; 2) Surgical treatment was performed in patients whose pathology result is lung adenocarcinoma; 3) Surgical treatment was performed in patients with benign pathology; 4)The newly diagnosed patients who have not received radiotherapy, chemotherapy, surgery or targeted therapy before.

Exclusion criteria

Exclusion criteria: 1) Patients whose primary tumor is extrapulmonary tumor; 2) Patients who have been treated for lung cancer; 3) Refusal of surgical treatment for patients without pathology; 4) Older patients or those who cannot tolerate surgery;

Design outcomes

Primary

MeasureTime frame
miRNA in serum exosomal;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactWei Han

Qingdao Municipal Hospital

sallyhan1@163.com+86 18561857838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026